Static Chart MoonLake Immunotherapeutics

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-14 pm EDT			5-day change	1st Jan Change
41.41 ^USD	-3.04%		-0.62%	-31.43%

Jun. 10	MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis	CI
May. 07	MoonLake Immunotherapeutics Q1 Net Loss Widens	MT

Duration

Period